This cooperation is intended to create new capabilities and growth opportunities. Respecting established partnerships and safeguarding partners’ interests and prior investments are principles and responsibilities shared by HYPNUS and Breas.

　　Recently, Guangzhou Hypnus Healthcare Co., Ltd. (HYPNUS) and Breas, a Swedish respiratory care company within Fosun Medtech, formally signed a strategic cooperation agreement.

　　With the support of Fosun Medtech's global industrial platform, the two companies will progressively advance collaboration across products and technology, quality and regulatory affairs, engineering and industrialization, and global markets and services. Together, they aim to strengthen sleep and respiratory health products and solutions for international markets.

　　For HYPNUS, the cooperation is not only an important step in global market development. It also connects the company's long-standing capabilities in products, algorithms, digital platforms and industrialization with more mature international regulatory, quality and commercial systems.

　　Complementary Strengths, Global Collaboration

　　Breas has a long-standing focus on respiratory health, with extensive experience in respiratory products, international quality and regulatory systems, global clinical applications and market networks.

　　HYPNUS has continued to build capabilities across intelligent devices, core algorithms, digital platforms, engineering development and industrialization, forming a system that spans screening and assessment, pressure titration, ventilatory support, outcome follow-up and long-term home management.

　　The cooperation is built on genuine technological and industrial complementarity and will be advanced through specific projects in the following areas:

　　• Product and Technology Collaboration: Advance product planning, performance optimization, intelligent algorithms and digital platform capabilities for sleep and home respiratory support products.

　　• Quality and Regulatory Collaboration: Draw on Breas's experience in international quality systems, regulatory access and global clinical applications to strengthen compliance and delivery capabilities for highly regulated markets.

　　• Engineering and Industrialization Collaboration: Leverage HYPNUS's strengths in engineering development, supply chain management and scalable manufacturing to deliver cooperation projects with high quality and efficiency.

　　• Global Market and Service Collaboration: Progressively advance market access, commercialization and localized service capabilities based on specific products and regional opportunities.

　　From Product Export to System-Level Collaboration

　　The significance of this cooperation extends beyond expanding overseas sales. HYPNUS will participate in global collaboration with its capabilities in products, algorithms, digital platforms, engineering industrialization and long-term services, accelerating the validation, optimization and implementation of innovation under higher quality, regulatory and clinical standards.

　　HYPNUS is not approaching this cooperation as a single-device or single-project initiative. The company will continue to strengthen its integrated “device + platform + service + long-term management” capabilities. Across screening and assessment, pressure titration, ventilatory support, outcome evaluation, adherence follow-up and long-term management, HYPNUS will further develop integrated solutions connecting clinical and home settings.

　　By deepening the integration of intelligent devices, core algorithms, continuous data, digital platforms and professional services, HYPNUS aims to ensure that devices not only provide stable and reliable respiratory support, but also serve as an important gateway to long-term health management—creating lasting value for healthcare institutions, partners and users worldwide.

　　Creating Additional Value, Protecting Long-Term Partnerships

　　Over the course of its global development, HYPNUS has built long-term relationships with customers, channel partners and service partners across many countries and regions. Their continued investment in market development, channel building, professional services and brand promotion is an important foundation of HYPNUS's global business—and a prerequisite that must be respected as any new cooperation moves forward.

　　HYPNUS and Breas share a clear view: the value of strategic cooperation should be reflected in new capabilities, new products and new market opportunities, not achieved by replacing or weakening established partnerships. Respecting existing contracts and commercial arrangements, and appropriately safeguarding partners' legitimate interests and prior investments in market development and service capabilities, are principles and responsibilities shared by both companies.

　　Under the strategic cooperation agreement now in place, the focus is on product development, quality and regulatory collaboration, engineering industrialization and global market cooperation. The agreement is designed to add value to—not disrupt—HYPNUS's established global partnerships, and it does not alter the cooperation arrangements already in place with existing customers and partners. HYPNUS will continue to honor existing contracts and commitments and maintain continuity in business operations, product supply and service support.

　　More importantly, the additional capabilities created through this cooperation—including international regulatory experience, product collaboration, quality systems, supply chain and service capabilities—will be translated into positive additional value for existing partners: more competitive products, more reliable supply, stronger compliance support, and more sustainable market and service capabilities.

　　Regardless of country or cooperation model, HYPNUS values every partner's trust and investment. This new strategic cooperation is not a replacement for established relationships; it is a further enhancement of HYPNUS's global partner network and service capabilities.

　　This cooperation marks HYPNUS's transition from global market expansion toward deeper system-level collaboration across technology, regulatory affairs, quality, industrialization and services—and will bring sustained additional value to existing partners worldwide.

　　Looking ahead, HYPNUS will continue to pursue independent innovation and open collaboration, growing together with Breas and its global partners to provide professional, reliable and sustainable products and solutions for healthcare institutions and users worldwide.

　　Rooted in China. Connected to the world.

　　Additional capabilities create shared value; long-term responsibility protects global partnerships